Biopharma Daily Stock Updates - 04/13/21

Apr 13, 20211 min read

$XBI $129 +2%

$MRNA +10% Supply update. source

$RIGL +15% Ph 2 data in hospitalized covid-19 patients. source

$BSGM -1% Completes enrollment in PURE EP 2.0 clinical trial. source

$AKUS -2% AK-OTOF receives FDA Orphan Drug and Rare Pediatric designations. source

$VTVT +34% TTP399 receives FDA Breakthrough Therapy designation for type 1 diabetes. source

$GERN +3% Initiation of ph 2 study of imetelstat for myelofibrosis. source

$AXLA +10% IND cleared for AXA1125 for NASH. source

$APLS +2% Ph 1b 24 mo data of pegcetacoplan in geographic atrophy. source

$FBIO -10% & $ATXI -24% FDA didn't provide approval decision yet. source

$AGTC -1% Licensing agreement for gene therapy treatment. source

$CERE +4% Non-dilutive financing based on milestone and royalty payments. source